Co-author on integration-site analysis
Appears in 1 story
Last updated Nov 1, 2026
Researcher studying where inserted DNA lands in the genome
CAR-T therapy starts with a patient's T cells being removed, engineered in a lab and reinfused. A paper in Cell reports skipping the removal: engineered retrotransposons, delivered as RNA in lipid nanoparticles, inserted a receptor gene into T cells inside living mice.
Updated Nov 1
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
